期刊文献+

白三烯B4与类风湿关节炎的治疗 被引量:1

下载PDF
导出
摘要 类风湿关节炎(RA)病理机制未明,目前对RA的治疗主要集中在控制疼痛和炎症、阻断骨质破坏的发展以及改善关节功能上[1]。传统治疗药物由于其系统用药的特性,在治疗的同时也产生一定的不良反应。白三烯(LT)B4是白细胞产生的一种脂质介质,系膜磷脂在磷脂酶(PL)A2作用下的花生四烯酸(AA)下游产物。研究证明在RA患者的关节腔和滑液中存在高浓度的LTB4。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2016年第7期1752-1754,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金项目(81260504) 南昌大学校级教学改革研究课题(NCUJGLX-14-1-111,NCUJGLX-14-1-72)
  • 相关文献

参考文献30

  • 1DonahRe KE,Gartlehner G,Jonas DE,et al.Systematic review:comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis〔J〕.Ann Intern Med,2008;148(2):124-34.
  • 2胡叶养,林广裕.白三烯受体拮抗剂在儿科疾病中的应用现状[J].临床儿科杂志,2009,27(2):189-192. 被引量:50
  • 3Boilard E,Lai Y,Larabee K,et al.A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis〔J〕.EMBO Mol Med,2010;2(5):172-87.
  • 4Hallett MB,Williams AS.Stopping the traffic:a route to arthritis therapy Neutrophil Signalling Group〔J〕.Eur J Immunol,2008;38(10):2650-3.
  • 5Tai N,Kuwabara K,Kobayashi M,et al.Cytosolic phospholipase A2 alpha inhibitor,pyrroxyphene,displays anti-arthritic and anti-bone destructive action in a murine arthritis model〔J〕.Inflamm Res,2010;59(1):53-62.
  • 6Raichel L,Berger S,Hadad N,et al.Reduction of c PLA2alpha overexpression:an efficient anti-inflammatory therapy for collagen-induced arthritis〔J〕.Eur J Immunol,2008;38(10):2905-15.
  • 7Zweifel BS,Hardy MM,Anderson GD,et al.A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors〔J〕.Eur J Pharmacol,2008;584(1):166-74.
  • 8Suh J,Yum EK,Cheon HG,et al.Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors〔J〕.Chem Biol Drug Des,2012;80(1):89-98.
  • 9Zweifel BS,Hardy MM,Anderson GD,et al. A rat air pouch model for e- valuating the efficacy and selectivity of 5-1ipoxygenase inhibitors [ J ]. Eur J Pharmaco1,2008 ; 584 ( 1 ) : 166 -74.
  • 10Blaho VA,Zhang Y,Hughes-Hanks JM,et al.5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis〔J〕.J Immunol,2011;186(5):3076-84.

二级参考文献38

  • 1瞿申红,李添应,陈彦球,林志斌,欧志英.白三烯受体拮抗剂和吸入性皮质激素在变应性鼻炎中的应用[J].临床耳鼻咽喉科杂志,2005,19(12):557-559. 被引量:14
  • 2彭秋莹,陈爱欢.白三烯研究进展及其在婴幼儿喘息性疾病中的作用[J].中华儿科杂志,2006,44(7):553-556. 被引量:94
  • 3隗远祥,王宏伟,康闽.白三烯受体途径在川崎病血管免疫损伤中的作用[J].实用儿科临床杂志,2007,22(9):663-664. 被引量:4
  • 4Peters-Golden M, Gleason MM, Togias A. Cysteinyl leukotrienes: muhi-functional mediators in allergic rhinitis [J]. Clin Exp Allergy, 2006,36 (6) : 689-703.
  • 5Scow DT, Luttermoser GK, Dickerson KS. Leukotriene inhibitors in the treatment of allergy and asthma [J]. Am Fam Physician, 2007,75 ( 1 ) : 65-70.
  • 6Figueroa DJ, Borish L, Baramki D, et al. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis [J]. Clin Exp Allergy. 2003,33(10) : 1380-1388.
  • 7Ho CY, Tan CT. Comparison of antileukotrienes and antihis-tamines in the treatment of allergic rhinitis [J]. Am J Rhinol, 2007,21 ( 4 ) : 439-443.
  • 8Philip G, Malmstrom K, Hampel FC, et ol. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring [J]. Clin Exp Allergy, 2002,32 ( 7 ) : 1020-1028.
  • 9Philip G, Williams-Herman D, Patel P, et al. Efficacy of mon-telukast for treating perennial allergic rhinitis [J]. Allergy Asthma Proc, 2007,28(3) :296-304.
  • 10Scadding GK, Durham SR, Mirakian R, et ol. BSACI guidelines for the management of allergic and non-allergic rhinitis [J]. Clin Exp Allergy ,2008,38( 1 ) : 19-42.

共引文献49

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部